Advertisement
Screener

PAVmed Inc. (PAVM) Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

PAVmed Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

PAVmed Inc. (PAVM) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$24.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13

  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $369.00K, a 25.15% decline year-over-year.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$393.00K.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$175.00K, a 127.60% decline year-over-year.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$116.00K.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$38.00K.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$304.00K, a 110.86% decline from fiscal 2023.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.80M.
  • PAVmed Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$554.00K, a 128.88% decline from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month
2026-06-30$369.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$24.00K
10-Q · filed 2026-08-13
-$199.00K
derived: sum of 3 quarters · filed 2026-08-13
-$315.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$393.00K
10-Q · filed 2026-05-14
-$568.00K
derived: sum of 2 quarters · filed 2026-05-14
-$684.00K
derived: sum of 3 quarters · filed 2026-05-14
-$191.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$175.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$291.00K
derived: sum of 2 quarters · filed 2026-03-27
$202.00K
derived: sum of 3 quarters · filed 2026-08-13
-$38.00K
10-K · filed 2026-03-27
2025-09-30-$116.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$377.00K
derived: sum of 2 quarters · filed 2026-08-13
$137.00K
10-Q · filed 2025-11-12
$771.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$493.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$253.00K
10-Q · filed 2026-08-13
$887.00K
derived: sum of 3 quarters · filed 2026-08-13
-$338.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$240.00K
10-Q · filed 2026-05-14
$394.00K
derived: sum of 2 quarters · filed 2026-05-14
-$831.00K
derived: sum of 3 quarters · filed 2026-05-14
-$698.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$634.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$591.00K
derived: sum of 2 quarters · filed 2026-03-27
-$458.00K
derived: sum of 3 quarters · filed 2026-03-27
-$304.00K
10-K · filed 2026-03-27
2024-09-30-$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$1.09M
derived: sum of 2 quarters · filed 2025-11-12
-$938.00K
10-Q · filed 2025-11-12
$81.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$133.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$287.00K
10-Q · filed 2025-08-14
$1.31M
derived: sum of 3 quarters · filed 2025-08-14
$1.84M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$154.00K
10-Q · filed 2025-05-15
$1.17M
derived: sum of 2 quarters · filed 2025-05-15
$1.71M
derived: sum of 3 quarters · filed 2025-05-15
$2.94M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$1.56M
derived: sum of 2 quarters · filed 2025-03-24
$2.78M
derived: sum of 3 quarters · filed 2025-03-24
$2.80M
10-K · filed 2025-03-24
2023-09-30$539.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.76M
derived: sum of 2 quarters · filed 2024-11-14
$1.78M
10-Q · filed 2024-11-14
$2.56M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
$1.24M
10-Q · filed 2024-08-12
$2.02M
derived: sum of 3 quarters · filed 2024-08-12
$2.01M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$18.00K
10-Q · filed 2024-05-13
$793.00K
derived: sum of 2 quarters · filed 2024-05-13
$790.00K
derived: sum of 3 quarters · filed 2024-05-13
$1.05M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$775.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
$772.00K
derived: sum of 2 quarters · filed 2024-03-25
$1.03M
derived: sum of 3 quarters · filed 2024-03-25
-$554.00K
10-K · filed 2024-03-25
2022-09-30-$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$259.00K
derived: sum of 2 quarters · filed 2023-11-13
-$1.33M
10-Q · filed 2023-11-13
$1.30M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$262.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$1.33M
10-Q · filed 2023-08-14
$1.31M
derived: sum of 3 quarters · filed 2023-08-14
$1.35M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$1.59M
10-Q · filed 2023-05-15
$1.04M
derived: sum of 2 quarters · filed 2023-05-15
$1.09M
derived: sum of 3 quarters · filed 2023-05-15
2021-12-31$2.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
$2.68M
derived: sum of 2 quarters · filed 2023-03-14
$1.92M
10-K · filed 2023-03-14
2021-09-30$44.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$715.00K
10-Q · filed 2022-11-14
2021-06-30-$759.00K
10-Q · filed 2022-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14